Guideline Provides Recommendations for Pharmacologic Treatment of Chronic Insomnia
The authors note that current evidence generally is weak, and more research into drugs’ efficacy is needed.
Neurology Reviews. 2017 April;25(4):18
March 27, 2017|Neurology Reviews
All recommendations were classified as weak, due to the task force’s low degree of certainty in the appropriateness of the patient-care strategy. Further study is required to determine the drugs’ efficacy or lack thereof, said the task force. “Clinicians must continue to exercise sound clinical judgment based not only on these recommendations, but also on clinical experience, prior patient response, patient preferences, and potential adverse effects,” the authors concluded.
—Erica Tricarico
Suggested Reading
Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349.
